Literature DB >> 25904356

Expression pattern of NeuN and GFAP during human fetal spinal cord development.

Jian-Hui Guo1, Wei Ma, Jin-Wei Yang, Yan Gao, Zhang Liang, Jia Liu, Dong-Yan Wang, Tao Luo, Jing-Ru Cheng, Li-Yan Li.   

Abstract

PURPOSE: The development of the human embryonic spinal cord is very complicated, and many cell types are involved in the process. However, the morphological characteristics of neuronal and glial cells during the development of the human fetal spinal cord have not been described. We investigated the systemic distributions and expression pattern of the cell type-specific markers Neuron-specific nuclear protein (NeuN) and glial fibrillary acidic protein (GFAP) during the development of the human fetal spinal cord, in order to clarify the detailed developmental changes of neuronal and glial cells in chronological and spatial aspects.
METHODS: A total of 35 fetuses, aged 3 weeks to 8 months of gestation (E3W-E8M), were studied. The markers used for immunohistochemical study were NeuN and GFAP.
RESULTS: The intracellular makers NeuN and GFAP were widely detected expression in different structures and cells during the development of the human fetal spinal cord, including the following: central canal, neuroepithelial layer, internal limiting membrane, mantle layer, marginal layer, basal plate, alar plate, ependymal layer, gray matter, white matter, neuron, astrocytes, and nerve fibers. However, there was an absence of GFAP in astrocytes during early fetal spinal cord development until E9W, and the appearance of GFAP-positive reactivity was later than that of neurons.
CONCLUSIONS: We consider that NeuN and GFAP can be used to identify neuronal and glial cells during the development of the human fetal spinal cord, and their distribution differs both chronologically and spatially. These characteristic expression patterns would give us a clue to better understand the developmental characteristics of the human spinal cord.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25904356     DOI: 10.1007/s00381-015-2713-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  33 in total

1.  Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival.

Authors:  Phillip J Albrecht; John P Dahl; Olivia K Stoltzfus; Robert Levenson; Steven W Levison
Journal:  Exp Neurol       Date:  2002-01       Impact factor: 5.330

2.  Three-dimensional distribution of astrocytes in zebrafish spinal cord.

Authors:  H Kawai; N Arata; H Nakayasu
Journal:  Glia       Date:  2001-12       Impact factor: 7.452

3.  Losses of NG2 and NeuN immunoreactivity but not astrocytic markers during early reperfusion following severe focal cerebral ischemia.

Authors:  Diane R Lee; Stephen C Helps; Ian L Gibbins; Michael Nilsson; Neil R Sims
Journal:  Brain Res       Date:  2003-11-07       Impact factor: 3.252

Review 4.  Glial specification in the vertebrate neural tube.

Authors:  David H Rowitch
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

Review 5.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

6.  Acute osmotic/stress stimuli induce a transient decrease of transcriptional activity in the neurosecretory neurons of supraoptic nuclei.

Authors:  M Lafarga; M T Berciano; L M Garcia-Segura; M A Andres; M Carmo-Fonseca
Journal:  J Neurocytol       Date:  1998-04

7.  Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in early human fetal nervous system.

Authors:  H B Sarnat; D Nochlin; D E Born
Journal:  Brain Dev       Date:  1998-03       Impact factor: 1.961

8.  Increased ciliary neurotrophic factor expression in reactive astrocytes following spinal cord injury in the rat.

Authors:  M Y Lee; C J Kim; S L Shin; S H Moon; M H Chun
Journal:  Neurosci Lett       Date:  1998-10-16       Impact factor: 3.046

9.  Astrocyte secreted proteins selectively increase hippocampal GABAergic axon length, branching, and synaptogenesis.

Authors:  Ethan G Hughes; Sarina B Elmariah; Rita J Balice-Gordon
Journal:  Mol Cell Neurosci       Date:  2009-10-20       Impact factor: 4.314

10.  Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

Authors:  B Knüsel; J W Winslow; A Rosenthal; L E Burton; D P Seid; K Nikolics; F Hefti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more
  4 in total

1.  Serum brain injury biomarkers are gestationally and post-natally regulated in non-brain injured neonates.

Authors:  Sandra Brooks; Barbara D Friedes; Frances Northington; Ernest Graham; Aylin Tekes; Vera J Burton; Gwendolyn Gerner; Jie Zhu; Raul Chavez-Valdez; Dhananjay Vaidya; Allen D Everett
Journal:  Pediatr Res       Date:  2021-12-18       Impact factor: 3.953

2.  Ontogeny of inter-alpha inhibitor protein (IAIP) expression in human brain.

Authors:  Boram Kim; Suzanne De La Monte; Virginia Hovanesian; Aparna Patra; Xiaodi Chen; Ray H Chen; Miles C Miller; Mehmet Halit Pinar; Yow-Pin Lim; Edward G Stopa; Barbara S Stonestreet
Journal:  J Neurosci Res       Date:  2019-12-04       Impact factor: 4.164

3.  Central projections and connections of lumbar primary afferent fibers in adult rats: effectively revealed using Texas red-dextran amine tracing.

Authors:  Shi-de Lin; Tao Tang; Ting-Bao Zhao; Shao-Jun Liu
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

4.  Human iPSC-Derived Endothelial Cells and Microengineered Organ-Chip Enhance Neuronal Development.

Authors:  Samuel Sances; Ritchie Ho; Gad Vatine; Dylan West; Alex Laperle; Amanda Meyer; Marlesa Godoy; Paul S Kay; Berhan Mandefro; Seigo Hatata; Chris Hinojosa; Norman Wen; Dhruv Sareen; Geraldine A Hamilton; Clive N Svendsen
Journal:  Stem Cell Reports       Date:  2018-03-22       Impact factor: 7.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.